Your browser doesn't support javascript.
loading
Capmatinib successfully overcomes tepotinib-induced intolerable peripheral edema.
Kunimasa, Kei; Kawamura, Takahisa; Tamiya, Motohiro; Inoue, Takako; Kuhara, Hanako; Nishino, Kazumi; Kumagai, Toru.
Afiliação
  • Kunimasa K; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Kawamura T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Tamiya M; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Inoue T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Kuhara H; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Nishino K; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Kumagai T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.
Thorac Cancer ; 12(24): 3426-3428, 2021 12.
Article em En | MEDLINE | ID: mdl-34695875
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperidinas / Piridazinas / Pirimidinas / Triazinas / Benzamidas / Edema / Adenocarcinoma de Pulmão / Imidazóis / Neoplasias Pulmonares Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperidinas / Piridazinas / Pirimidinas / Triazinas / Benzamidas / Edema / Adenocarcinoma de Pulmão / Imidazóis / Neoplasias Pulmonares Idioma: En Ano de publicação: 2021 Tipo de documento: Article